Edgewise Therapeutics - A Movement in Muscle
Jan 13, 2025 · At Edgewise, we’re bringing our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases – with …
Edgewise Therapeutics Strengthens Leadership Team to Support …
16 hours ago · BOULDER, Colo., January 22, 2025--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes …
Edgewise Therapeutics Provides Corporate Update and …
BOULDER, Colo., January 13, 2025 -- (BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent …
Edgewise Therapeutics, Inc. - Investor Relations
Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. Guided by our approach …
Edgewise Therapeutics Announces Positive Top-Line Data from …
Sep 19, 2024 · EDG-7500 is a novel oral, selective, cardiac sarcomere modulator, specifically designed to slow early contraction velocity and address impaired cardiac relaxation associated …
Precision Therapeutics for Serious Muscle Diseases
Learn more about how our science is driving a new understanding of muscle and its potential to transform human health. See our pipeline of the novel precision therapeutics for serious …
About Edgewise Therapeutics
At Edgewise, we appreciate the life-limiting impact of serious muscle diseases. We are committed to helping people and families living with them by pursuing a new era of muscle-focused …
Edgewise Therapeutics Provides Corporate Update and …
Jan 13, 2025 · BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent …
Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain ...
2 days ago · Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for …
Edgewise Therapeutics Strengthens Leadership Team to Support …
16 hours ago · Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The …
- Some results have been removed